These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
573 related items for PubMed ID: 21788055
1. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens. Epstein JI. J Urol; 2011 Sep; 186(3):790-7. PubMed ID: 21788055 [Abstract] [Full Text] [Related]
2. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H. J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340 [Abstract] [Full Text] [Related]
3. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings. Karram S, Trock BJ, Netto GJ, Epstein JI. Am J Surg Pathol; 2011 Sep; 35(9):1351-5. PubMed ID: 21836493 [Abstract] [Full Text] [Related]
4. The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system. van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-Van De Kaa CA. BJU Int; 2008 Aug; 102(4):438-41. PubMed ID: 18336608 [Abstract] [Full Text] [Related]
5. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. Noguchi M, Stamey TA, McNeal JE, Yemoto CM. J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833 [Abstract] [Full Text] [Related]
6. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy. Gallina A, Maccagnano C, Suardi N, Capitanio U, Abdollah F, Raber M, Salonia A, Scattoni V, Rigatti P, Montorsi F, Briganti A. BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108 [Abstract] [Full Text] [Related]
13. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management. Ochiai A, Troncoso P, Chen ME, Lloreta J, Babaian RJ. J Urol; 2005 Dec; 174(6):2164-8, discussion 2168. PubMed ID: 16280756 [Abstract] [Full Text] [Related]
15. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens. Park EA, Lee HJ, Kim KG, Kim SH, Lee SE, Choe GY. Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059 [Abstract] [Full Text] [Related]
16. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. Cupp MR, Bostwick DG, Myers RP, Oesterling JE. J Urol; 1995 May; 153(5):1543-8. PubMed ID: 7714976 [Abstract] [Full Text] [Related]
17. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population? Anast JW, Andriole GL, Bismar TA, Yan Y, Humphrey PA. Urology; 2004 Sep; 64(3):544-50. PubMed ID: 15351590 [Abstract] [Full Text] [Related]
18. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. Freedland SJ, Presti JC, Terris MK, Kane CJ, Aronson WJ, Dorey F, Amling CL, SEARCH Database Study Group. J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734 [Abstract] [Full Text] [Related]
19. Implementation of a map in radical prostatectomy specimen allows visual estimation of tumor volume. Bettendorf O, Oberpenning F, Köpke T, Heinecke A, Hertle L, Boecker W, Semjonow A. Eur J Surg Oncol; 2007 Apr; 33(3):352-7. PubMed ID: 17175129 [Abstract] [Full Text] [Related]
20. Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence: A new proposal for the substaging of pT3a prostate cancer. Sung MT, Lin H, Koch MO, Davidson DD, Cheng L. Am J Surg Pathol; 2007 Feb; 31(2):311-8. PubMed ID: 17255778 [Abstract] [Full Text] [Related] Page: [Next] [New Search]